Email bookmark
Font : A-A+

Drug information on Coekastle KID (Montelukast) from Koye Pharmaceuticals Pvt. ltd.

Coekastle KID

  Disintegrating Tablet
Koye Pharmaceuticals Pvt. ltd.
Generic : Montelukast
Medindia currently has information on 3065 generic drugs and 109,997 brands that have their prices listed. New drugs with their prices are listed as and when they get approved by the drug controller. Please do write to us ( if a drug is missing from our comprehensive drug price list.

Medical Condition(s) for which Coekastle KID may be prescribed

Side effects of Coekastle KID

   Most Common : Diarrhea, dizziness, cough, headache, vomiting, stomach pain and sore throat.

   Miscellaneous : Hoarseness, itching, rash, hives, fever, flu-like symptoms, Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).

Dosage & When it is to be taken (Indications)

Adult- PO- The recommended dose is 10 mg/day.

How to use Coekastle KID?

It comes as a tablet to take by mouth with or without food.

When is Coekastle KID not to be taken? (Contraindications)


Warnings and Precautions for Coekastle KID

Caution should be exercised in patients with history of liver disease, suicidal thoughts, mental problem, any allergy, who are taking other medications, during pregnancy and breastfeeding.

• It may cause drowsiness or dizziness, do not drive a car or operate machinery while taking this medication.

Other Precautions for Coekastle KID

Avoid excess dosage.

Storage Conditions for Coekastle KID

Store it at controlled room temperature (15-30°C).

♦ Safety Labeling Changes Approved By FDA

Disclaimer : The Price of the drugs indicated above may not match the actual price at which they are sold. Prices can change depending on many factors, including GST. These are only approximate indicative prices of the drug.
Buy Medicines (Drug) at Concessional Price from India
Substitutes for Coekastle KID

View all
Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.